For Institutional Investors in the US

Janus Henderson Blog

We believe in the sharing of expert insight for better investment and business decisions. We call this ethos Knowledge Shared.

Latest Posts

Subscribe for relevant insights delivered straight to your inbox

The Affordable Care Act Lives On
Healthcare

The Affordable Care Act Lives On

The Supreme Court’s decision to uphold the legislation may finally bring an end to challenges to the law and further expand health care in the U.S.

Biopharma’s Targeted Approach to Growth
Healthcare

Biopharma’s Targeted Approach to Growth

A new drug targeting a common mutation found in tumors represents a breakthrough in cancer therapy and a potential new source of growth for biopharma.

Making Sense of COVID-19 Vaccine IP Waivers

Making Sense of COVID-19 Vaccine IP Waivers

Why U.S. support for waiving intellectual property protections for COVID-19 vaccines does not spell the end of biotech growth.

Vaccines Prove Their Worth for Global Health Care
Coronavirus Healthcare

Vaccines Prove Their Worth for Global Health Care

In places where vaccination rates are rising, COVID-19 cases are dropping dramatically. What that means for ending the pandemic and health care long term.

Access to Medicine: The Need for Innovation, Partnerships and Data Capture

Access to Medicine: The Need for Innovation, Partnerships and Data Capture

How pharmaceutical companies are addressing the issue of inequitable access to medicine.

COVID Variants: The Impact on Pandemic Trajectory, Biopharma Stocks
Coronavirus Healthcare

COVID Variants: The Impact on Pandemic Trajectory, Biopharma Stocks

Making sense of the latest developments around COVID-19 variants and what investors should consider now.

Health Care Builds Momentum

Health Care Builds Momentum

Portfolio Manager Andy Acker says the health care sector looks set to ride a number of positive trends into 2021.

COVID-19 Vaccine Beats Expectations
Coronavirus Healthcare

COVID-19 Vaccine Beats Expectations

How a novel vaccine candidate from Pfizer and BioNTech could shape the trajectory of the global pandemic.

A Potential Turning Point in the Battle Against COVID-19
Coronavirus Healthcare

A Potential Turning Point in the Battle Against COVID-19

Delivering better-than-expected trial data, a vaccine candidate from Pfizer and BioNTech could mark the beginning of the end of the pandemic and boost confidence in an economic recovery, now underway.

Affordable Care Act: “Reports of My Death Are Greatly Exaggerated”
Elections Healthcare Volatility

Affordable Care Act: “Reports of My Death Are Greatly Exaggerated”

A look at the future of the ACA following the passing of Supreme Court Justice Ruth Bader Ginsburg and what it means for health care stocks.

Health Care Gains an Edge
Coronavirus Elections Healthcare

Health Care Gains an Edge

How COVID-19 is shifting the discourse around health care during the 2020 U.S. election.